Back to GetFilings.com




QuickLinks -- Click here to rapidly navigate through this document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-Q


ý  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2002

Or

o  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION
PERIOD FROM                        TO                         

Commission File Number 0-22660


TRIQUINT SEMICONDUCTOR, INC.
(Exact Name of Registrant as Specified in Its Charter)

Delaware   95-3654013
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer
Identification Number)

2300 NE Brookwood Parkway
Hillsboro, OR 97124
(Address of Principal Executive Offices) (Zip Code)

(503) 615-9000
(Registrant's Telephone Number, Including Area Code)


        Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý    No o

        As of October 28, 2002, there were 132,486,447 shares of the registrant's common stock outstanding.





TRIQUINT SEMICONDUCTOR, INC.

INDEX

 
   
  Page No.
PART I.   FINANCIAL INFORMATION    

Item 1.

 

Financial Statements

 

3

 

 

Condensed Consolidated Statements of Operations—Three and nine months ended September 30, 2002 and 2001

 

3

 

 

Condensed Consolidated Balance Sheets—September 30, 2002 and December 31, 2001

 

4

 

 

Condensed Consolidated Statements of Cash Flows—Nine months ended September 30, 2002 and 2001

 

5

 

 

Notes to Condensed Consolidated Financial Statements

 

6

Item 2.

 

Management's Discussion and Analysis of Financial Condition and Results of Operations

 

15

Item 3.

 

Qualitative and Quantitative Disclosures about Market and Interest Rate Risk

 

40

Item 4.

 

Controls and Procedures

 

40

PART II.

 

OTHER INFORMATION

 

 

Item 1.

 

Legal Proceedings

 

41

Item 6.

 

Exhibits and Reports on Form 8-K

 

41

SIGNATURES

 

42

CERTIFICATION

 

43

2



PART I—FINANCIAL INFORMATION

ITEM 1: FINANCIAL STATEMENTS

TRIQUINT SEMICONDUCTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share amounts)
(Unaudited)

 
  Three Months Ended
  Nine Months Ended
 
 
  September 30,
2002

  September 30,
2001

  September 30,
2002

  September 30,
2001

 
Revenues   $ 71,020   $ 80,820   $ 194,603   $ 269,531  
Cost of goods sold     45,891     47,292     126,101     155,942  
   
 
 
 
 
    Gross profit     25,129     33,528     68,502     113,589  
Operating expenses:                          
  Research, development and engineering     16,667     13,180     42,108     36,878  
  Selling, general and administrative     9,938     11,432     31,296     35,247  
  Impairment of long lived assets     5,829         5,829      
  Acquisition related costs     8,575     7,546     8,575     7,546  
  Reduction in workforce     1,011     15     1,011     1,077  
   
 
 
 
 
    Total operating expenses     42,020     32,173     88,819     80,748  
   
 
 
 
 
    Income (loss) from operations     (16,891 )   1,355     (20,317 )   32,841  
   
 
 
 
 
Other income (expense):                          
  Interest income (expense) and other     (408 )   2,325     (14 )   10,644  
  Impairment of equity investments     (4,850 )   (1,453 )   (8,100 )   (1,453 )
  Retirement of debt     3,711     9,401     6,009     9,401  
  Foreign currency gains, net             4,570      
   
 
 
 
 
    Total other income (expense), net     (1,547 )   10,273     2,465     18,592  
   
 
 
 
 
    Income before income tax (benefit)     (18,438 )   11,628     (17,852 )   51,433  
Income tax expense (benefit)     (9,224 )   4,996     (8,873 )   18,052  
   
 
 
 
 
    Net income (loss)   $ (9,214 ) $ 6,632   $ (8,979 ) $ 33,381  
   
 
 
 
 
Per share data:                          
    Basic   $ (0.07 ) $ 0.05   $ (0.07 ) $ 0.26  
   
 
 
 
 
    Weighted-average common shares     132,168,463     130,021,015     131,704,547     129,506,785  
   
 
 
 
 
    Diluted   $ (0.07 ) $ 0.05   $ (0.07 ) $ 0.25  
   
 
 
 
 
    Weighted-average common and common equivalent shares     132,168,463     135,871,478     131,704,547     135,955,486  
   
 
 
 
 

See notes to Condensed Consolidated Financial Statements.

3



TRIQUINT SEMICONDUCTOR, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)

 
  September 30,
2002

  December 31,
2001(1)

 
Assets              
Current assets:              
  Cash and cash equivalents   $ 209,031   $ 261,728  
  Investments in marketable securities     127,454     246,775  
  Accounts receivable, net     43,411     34,532  
  Inventories, net     33,264     34,836  
  Deferred income taxes     11,387     11,359  
  Other current assets     8,664     12,623  
   
 
 
    Total current assets     433,211     601,853  
   
 
 
Long-term investments in marketable securities     118,951     73,028  
Property, plant and equipment, net     207,610     214,402  
Deferred income taxes     34,460     23,761  
Other investment     88,093     73,617  
Restricted long-term assets     17,408     14,547  
Other non-current assets, net     89,328     19,665  
   
 
 
    Total assets   $ 989,061   $ 1,020,873  
   
 
 
Liabilities and Stockholders' Equity              
Current liabilities:              
  Current installments of capital lease and installment note obligations   $ 457   $ 1,580  
  Accounts payable and accrued expenses     38,161     39,660  
   
 
 
    Total current liabilities     38,618     41,240  
Long-term debt, less current installments     268,755     296,859  
   
 
 
    Total liabilities     307,373     338,099  
   
 
 
Stockholders' equity:              
  Common stock     459,910     451,834  
  Accumulated other comprehensive income     80     458  
  Unearned ESOP compensation     (195 )   (390 )
  Retained earnings     221,893     230,872  
   
 
 
    Total stockholders' equity     681,688     682,774  
   
 
 
    Total liabilities and stockholders' equity   $ 989,061   $ 1,020,873  
   
 
 

(1)
The information in this column was derived from the Company's audited financial statements as of December 31, 2001.

See notes to Condensed Consolidated Financial Statements.

4



TRIQUINT SEMICONDUCTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

 
  Nine Months Ended
 
 
  September 30,
2002

  September 30,
2001

 
Cash flows from operating activities:              
  Net income (loss)   $ (8,979 ) $ 33,381  
  Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:              
    Depreciation and amortization     27,619     21,376  
    Deferred income taxes     (10,727 )   3,690  
    Income tax benefit of stock option exercises     2,329     8,553  
    Adjustment to conform year end of pooled entity         39,099  
    Impairment of assets     5,829      
    Acquired in-process research and development     8,575      
    Loss on disposal of assets     421     179  
    Gain on sale of subsidiary         (767 )
    Gain on extinguishment of debt     (6,009 )   (9,401 )
    Loss on investments     8,100     2,761  
    Realized gain on forward contract     (4,570 )    
    Unrealized ESOP compensation     195     195  
    Changes in assets and liabilities, net of acquisitions:              
    (Increase) decrease in:              
      Accounts receivable     (8,879 )   26,832  
      Inventories     1,572     13,578  
      Prepaid expenses and other assets     4,481     (4,621 )
    Increase (decrease) in:              
      Accounts payable and accrued expenses     2,703     (10,947 )
   
 
 
    Net cash provided by operating activities     17,254     123,908  

Cash flows from investing activities:

 

 

 

 

 

 

 
  Purchase of available-for-sale investments     (336,008 )   (247,350 )
  Maturity/sale of available-for-sale investments     409,684     289,672  
  Purchase of held-to-maturity investments         (225,483 )
  Maturity of held-to-maturity investments         322,951  
  Purchase of long term investments     (14,476 )   (6,500 )
  Decrease (increase) in restricted long-term assets     (2,861 )   38,250  
  Advances to or investment in other companies     (17,102 )    
  Infineon acquisition     (49,536 )    
  IBM acquisition     (23,388 )    
  Capital expenditures     (19,391 )   (115,847 )
  Proceeds from sale of subsidiary         1,362  
  Proceeds from sale of assets         15  
   
 
 
    Net cash provided by (used in) investing activities     (53,079 )   57,070  

Cash flows from financing activities:

 

 

 

 

 

 

 
  Principal payments under capital lease obligations     (1,482 )   (2,169 )
  Purchase of treasury stock         (9,778 )
  Repurchase of convertible subordinated notes     (21,137 )   (37,871 )
  Issuance of common stock, net     5,747     8,120  
   
 
 
    Net cash used in financing activities     (16,872 )   (41,698 )
   
Net increase (decrease) in cash and cash equivalents

 

 

(52,697

)

 

139,280

 

Cash and cash equivalents at the beginning of the period

 

 

261,728

 

 

163,747

 
   
 
 
Cash and cash equivalents at the end of the period   $ 209,031   $ 303,027  
   
 
 

See notes to Condensed Consolidated Financial Statements

5



TRIQUINT SEMICONDUCTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1.    Basis of Presentation

        The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America. However, certain information or footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed, or omitted, pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). In the opinion of management, the statements include all adjustments necessary (which are of a normal and recurring nature) for the fair presentation of the results of the interim periods presented. These condensed consolidated financial statements should be read in conjunction with the audited financial statements of TriQuint Semiconductor, Inc. (the "Company") for the fiscal year ended December 31, 2001, as included in the Company's 2001 Annual Report on Form 10-K as filed with the SEC on March 27, 2002.

        The Company's fiscal quarters end on the Saturday nearest the end of the calendar quarter. For convenience, the Company has indicated that its third quarter ended on September 30. The Company's fiscal year ends on December 31.

        Certain prior period amounts have been reclassified to conform to the current period presentation.

2.    Acquisitions

        On July 19, 2001, Sawtek, Inc. became a wholly owned subsidiary of the Company. The Company issued approximately 48.8 million shares of common stock in exchange for all the outstanding common stock of Sawtek. Additionally, outstanding options to purchase Sawtek common stock were exchanged for approximately 2.6 million options to purchase the Company's common stock. The transaction was accounted for as a pooling-of-interests transaction and qualified as a tax-free exchange of shares.

        All financial information set forth in this document has been restated to include the historical information of Sawtek.

        On July 1, 2002, the Company closed the acquisition of the GaAs Business of Infineon Technologies AG ("Infineon"). The Company added approximately 60 employees as part of the acquisition. The acquisition was accounted for as a purchase transaction and the results of operations are included in the condensed consolidated financial statements from the date of acquisition. At the closing date, the Company paid Infineon EUR50.0 million ($45.0 million at forward contract rate of $.9000/EUR1.00), of which EUR10.0 million ($9.0 million at forward contract rate of $.9000/EUR1.00) represents an earnout deposit. Pursuant to the purchase agreement, Infineon may earn up to an additional EUR74.0 million over a 24-month period based upon revenues generated by the acquired business, for an aggregate purchase price of EUR124.0 million. Subsequent to the close of the acquisition, certain fixed assets were also purchased for EUR5.5 million less EUR1.5 million in funded liabilities acquired ($4.0 million at various spot rates). There are also various other guarantees and contingencies which could affect the amount of the final purchase price. The Company acquired this business to strengthen its European presence and to expand its market and product offerings in the wireless communications industry.

6


        Details of the purchase price are as follows (in thousands):

Cash paid at closing   $ 53,559  
Acquisition costs     547  
Less: Earnout deposit     (9,910 )
   
 
Total purchase price   $ 44,196  
   
 

        The purchase price was allocated to the assets and liabilities based on fair values as follows (in thousands):

Machinery and equipment   $ 5,440  
Identifiable intangibles     13,373  
Acquired in-process research and development     2,693  
Goodwill     24,003  
Liabilities     (1,313 )
   
 
Allocated purchase price   $ 44,196  
   
 

        Pro forma results of operations as if this acquisition had closed on January 1, 2002 and for the corresponding periods in the preceding year are as follows (in thousands, except per share amounts):

 
  As Reported
  Pro forma
 
 
  Three Months
Ended
September 30,
2002

  Three Months
Ended
September 30,
2001

  Three Months
Ended
September 30,
2002

  Three Months
Ended
September 30,
2001

 
Revenues   $ 71,020   $ 80,820   $ 71,020   $ 88,848  
Net income (loss)     (9,214 )   6,632     (9,214 )   (284 )
Earnings (loss) per share—basic     (0.07 )   0.05     (0.07 )    
Earnings (loss) per share—diluted   $ (0.07 ) $ 0.05   $ (0.07 ) $  

 


 

As Reported


 

Pro forma

 
  Nine Months
Ended
September 30,
2002

  Nine Months
Ended
September 30,
2001

  Nine Months
Ended
September 30,
2002

  Nine Months
Ended
September 30,
2001

Revenues   $ 194,603   $ 269,531   $ 207,842   $ 293,615
Net income (loss)     (8,979 )   33,381     (20,966 )   14,336
Earnings (loss) per share—basic     (0.07 )   0.26     (0.16 )   0.11
Earnings (loss) per share—diluted   $ (0.07 ) $ 0.25   $ (0.16 ) $ 0.11

        In connection with this acquisition, the Company obtained a third-party valuation of the assets for purposes of the purchase price allocation. Acquired in-process research and development ("IPR&D") assets were expensed at the date of acquisition in accordance with FASB Interpretation No. 4 ("FIN 4"), Applicability of FASB Statement No. 2 to Business Combinations Accounted for by the Purchase Method. The value assigned to IPR&D related to research projects for which technological feasibility had not been established and no future alternative uses existed. The fair value was determined using the income approach, which discounts expected future cash flows from projects under development to their net present value using a risk adjusted rate. Each project was analyzed to determine the following: the technological innovations included; the utilization of core technology; the complexity, cost and time to complete development; any alternative future use or current technological feasibility; and the stage of completion. Future cash flows were estimated based upon management's estimates of revenues expected to be generated upon completion of the projects and the beginning of commercial sales and related operating

7



costs. The projections assume that the technologies will be successful and that the product's development and commercialization will meet management's time schedule. The discount rates utilized ranged from 25% to 50% and were based on the novelty of the technology, the risks remaining to complete each project, and the extent of the Company's familiarity with the technology. The estimated cost to complete this IPR&D is approximately $900,000.

        On July 1, 2002, the Company closed the acquisition of a portion of the assets of IBM's wireless phone chipset business. The Company added 9 employees as part of the acquisition. The acquisition was accounted for as a purchase transaction and the results of operations are included in the condensed consolidated financial statements from the date of acquisition. At the closing date, we paid $21.8 million to IBM for the related assets, of which $5.0 million represents an earnout deposit. Subsequent adjustments to the purchase price contingent upon business volumes could increase the final aggregate purchase price up to $40.0 million. The Company acquired this business to expand its market and product offerings in the wireless communications industry and to strengthen its capabilities in silicon germanium process technology.

        Details of the purchase price are as follows (in thousands):

Cash paid at closing   $ 21,750  
Acquisition costs     1,638  
Less: Earnout deposit     (5,000 )
   
 
Total purchase price   $ 18,388  
   
 

        The purchase price was allocated to the assets and liabilities based on fair values as follows (in thousands):

Machinery and equipment   $ 1,959
Technology licenses     1,635
Acquired in-process research and development     5,900
Current technology     1,077
Backlog     158
Goodwill     7,659
   
Allocated purchase price   $ 18,388
   

        In a transaction related to this acquisition, the Company transferred $1.3 million of the acquired machinery and equipment, $1.0 million of the technology licenses, $733,000 of acquired workforce and $11.0 million in cash to a privately held technology company in exchange for a note receivable of $14.0 million.

        Pro forma results of operations have not been presented for this acquisition because its effects were not material on either an individual or aggregate basis.

        In connection with this acquisition, the Company obtained a third-party valuation of the assets for purposes of the purchase price allocation. Acquired IPR&D assets were expensed at the date of acquisition in accordance with FIN 4. The value assigned to IPR&D related to research projects for which technological feasibility had not been established and no future alternative uses existed. The fair value was determined using the income approach, which discounts expected future cash flows from projects under development to their net present value using a risk adjusted rate. Each project was analyzed to determine the following: the technological innovations included; the utilization of core technology; the complexity, cost and time to complete development; any alternative future use or current technological feasibility; and

8



the stage of completion. Future cash flows were estimated based upon management's estimates of revenues expected to be generated upon completion of the projects and the beginning of commercial sales and related operating costs. The projections assume that the technologies will be successful and that the product's development and commercialization will meet management's time schedule. The discount rate utilized was 29% and was based on the novelty of the technology, the risks remaining to complete each project, and the extent of the Company's familiarity with the technology. The estimated cost to complete this IPR&D is approximately $40,000.

3.    Segment Information

        SFAS No. 131, Disclosures About Segments of an Enterprise and Related Information ("SFAS 131") establishes standards for the reporting by public business enterprises of information about operating segments, products and services, geographic areas and major customers. The method for determining what information to report is based on the way that management organizes the segments within the Company for making operating decisions and assessing financial performance. The Company has aggregated its businesses into a single reportable segment as allowed under SFAS 131 because they have similar long-term economic characteristics, including average gross margin. In addition, they are similar in regards to (a) nature of products and production processes, (b) type of customers and (c) method used to distribute products. Accordingly, the Company describes its reportable segment as high-performance, integrated circuits and electronic filters for the wireless and broadband communications markets. All of the Company's revenues result from sales in its products lines.

        Our sales outside of the United States were 56% of revenues for the nine months ended September 30, 2002 and 42% of revenues for the nine months ended September 30, 2001.

4.    Net Income (Loss) Per Share

        Earnings (loss) per share is presented as basic and diluted net income (loss) per share. Basic net income (loss) per share is net income (loss) available to common stockholders divided by the weighted-average number of common shares outstanding. Diluted net income (loss) per share is similar to basic except that the denominator includes potential common shares that, had they been issued, would have had a dilutive effect.

        The following is a reconciliation of the basic and diluted earnings (loss) per share (in thousands, except per share amounts):

 
  Three Months Ended
September 30,

  Nine Months Ended
September 30,

 
  2002
  2001
  2002
  2001
Income (loss) available to stockholders   $ (9,214 ) $ 6,632   $ (8,979 ) $ 33,381
   
 
 
 
Shares for basic earnings per share:                        
  Weighted-average common shares     132,169     130,021     131,705     129,507
Effect of dilutive securities:                        
  Stock options         5,850         6,448
   
 
 
 
Shares for dilutive earnings per share:     132,169     135,871     131,705     135,955
   
 
 
 
Per share data:                        
  Basic   $ (0.07 ) $ 0.05   $ (0.07 ) $ 0.26
   
 
 
 
  Diluted   $ (0.07 ) $ 0.05   $ (0.07 ) $ 0.25
   
 
 
 

        Stock options and other exercisable convertible securities totaling approximately 20,556,000 and 18,927,000 shares for the three and nine months ended September 30, 2002 and 11,979,000 and 10,156,000

9



shares for the three and nine months ended September 30, 2001 were not included in the diluted net income (loss) per share calculations, because to do so would have been antidilutive.

5.    Income Taxes

        Deferred tax assets and liabilities are determined based on the temporary differences between the financial reporting and tax basis of assets and liabilities, applying enacted statutory tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized.

        The provision for income taxes has been recorded based on the current estimate of the Company's annual effective tax rate. For periods of income reported, this rate differs from the federal statutory rate primarily because of tax exempt income earned by the Company's Costa Rican facility, which currently operates in a free trade zone, tax exempt interest income earned on certain cash and investment items within the Company's portfolio and tax credits, which are offset by state taxes and other items.

6.    Investments in Marketable Securities

        The Company classifies its investments in marketable securities as available-for-sale in accordance with Statement of Financial Accounting Standards ("SFAS") No. 115, Accounting for Certain Investments in Debt and Equity Securities ("SFAS 115"). Investments in marketable securities are comprised of U.S. treasury securities and obligations of U.S. government agencies, municipal notes and bonds, corporate debt securities and other investments. Investments are recorded at fair value. Unrealized gains and losses, net of tax, on investments are reported as a separate component of stock